Summary
44 / 100 · Bulios Score
What speaks for it
- Revenue grew by 26% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It earns 6.5 USD a year on every 100 USD of invested capital.
What to watch
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
- Operating profit covers the interest on its debt only 1.6 times.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 21% a year over 5 years. Over the last 3 years it grew by 26% a year.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $351.6M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 2,503.6 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.21%
You receive $0.63 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 1
No analyst has published a price target.
50% of the analysts recommend buying.
Analysts in detail